These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1981830)

  • 41. Amplification of c-erbB-2 oncogene in human adenocarcinomas in vivo.
    Yokota J; Yamamoto T; Toyoshima K; Terada M; Sugimura T; Battifora H; Cline MJ
    Lancet; 1986 Apr; 1(8484):765-7. PubMed ID: 2870269
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HER-2/neu oncogene expression and DNA ploidy analysis in breast cancer.
    Bacus SS; Bacus JW; Slamon DJ; Press MF
    Arch Pathol Lab Med; 1990 Feb; 114(2):164-9. PubMed ID: 1967930
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of c-erbB-2 oncoprotein in primary human tumors: an immunohistochemistry study.
    Suwanagool P; Parichatikanond P; Maeda S
    Asian Pac J Allergy Immunol; 1993 Dec; 11(2):119-22. PubMed ID: 7915904
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Correlation of HER-2/neu amplification with expression and with other prognostic factors in 1103 breast cancers.
    Ciocca DR; Fujimura FK; Tandon AK; Clark GM; Mark C; Lee-Chen GJ; Pounds GW; Vendely P; Owens MA; Pandian MR
    J Natl Cancer Inst; 1992 Aug; 84(16):1279-82. PubMed ID: 1353538
    [No Abstract]   [Full Text] [Related]  

  • 45. The role of the HER-2/neu oncogene in gynecologic cancers.
    Cirisano FD; Karlan BY
    J Soc Gynecol Investig; 1996; 3(3):99-105. PubMed ID: 8796816
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serum levels of HER-2 neu (C-erbB-2) correlate with overexpression of p185neu in human ovarian cancer.
    McKenzie SJ; DeSombre KA; Bast BS; Hollis DR; Whitaker RS; Berchuck A; Boyer CM; Bast RC
    Cancer; 1993 Jun; 71(12):3942-6. PubMed ID: 8099528
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Amplification and overexpression of the erbB-2 gene in human tumors: its involvement in tumor development, significance as a prognostic factor, and potential as a target for cancer therapy.
    Hynes NE
    Semin Cancer Biol; 1993 Feb; 4(1):19-26. PubMed ID: 8095411
    [TBL] [Abstract][Full Text] [Related]  

  • 48. c-erbB-2 amplification and overexpression in breast cancer: evaluation and comparison of Southern blot, slot blot, ELISA and immunohistochemistry.
    Dawkins HJ; Robbins PD; Sarna M; Carrello S; Harvey JM; Sterrett GF
    Pathology; 1993 Apr; 25(2):124-32. PubMed ID: 8103591
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enhanced c-erbB-2/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1A.
    Yu D; Wolf JK; Scanlon M; Price JE; Hung MC
    Cancer Res; 1993 Feb; 53(4):891-8. PubMed ID: 8094034
    [TBL] [Abstract][Full Text] [Related]  

  • 50. c-erbB-2 oncogene as a prognostic marker in breast cancer.
    Perren TJ
    Br J Cancer; 1991 Mar; 63(3):328-32. PubMed ID: 1672251
    [No Abstract]   [Full Text] [Related]  

  • 51. Application of fine-needle aspiration to the demonstration of ERBB2 and MYC expression by in situ hybridization in breast carcinoma.
    Soini Y; Mannermaa A; Winqvist R; Kamel D; Poikonen K; Kiviniemi H; Pääkkö P
    J Histochem Cytochem; 1994 Jun; 42(6):795-803. PubMed ID: 7910618
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Distribution and patterns of staining of Neu oncogene product in benign and malignant breast diseases.
    Hanna W; Kahn HJ; Andrulis I; Pawson T
    Mod Pathol; 1990 Jul; 3(4):455-61. PubMed ID: 1977159
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HER2 (c-erbB-2) oncoprotein expression in colorectal adenocarcinoma: an immunohistological study using three different antibodies.
    Arnaout AH; Dawson PM; Soomro S; Taylor P; Theodorou NA; Feldmann M; Fendly BM; Shepard HM; Shousha S
    J Clin Pathol; 1992 Aug; 45(8):726-7. PubMed ID: 1357006
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Int-2/FGF3 amplification is a better independent predictor of relapse than c-myc and c-erbB-2/neu amplifications in primary human breast cancer.
    Champème MH; Bièche I; Hacène K; Lidereau R
    Mod Pathol; 1994 Dec; 7(9):900-5. PubMed ID: 7892157
    [TBL] [Abstract][Full Text] [Related]  

  • 55. C-erbB-2-oncogene expression in breast carcinoma: analysis by S1 nuclease protection assay and immunohistochemistry in relation to clinical parameters.
    Tanner B; Friedberg T; Mitze M; Beck T; Oesch F; Knapstein PG
    Gynecol Oncol; 1992 Nov; 47(2):228-33. PubMed ID: 1361480
    [TBL] [Abstract][Full Text] [Related]  

  • 56. erbB-2 expression in well-differentiated adenocarcinoma of the stomach predicts shorter survival after curative resection.
    Motojima K; Furui J; Kohara N; Izawa K; Kanematsu T; Shiku H
    Surgery; 1994 Mar; 115(3):349-54. PubMed ID: 7907434
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Amplification and overexpression of the EGF receptor and c-erbB-2 proto-oncogenes in human stomach cancer.
    Lemoine NR; Jain S; Silvestre F; Lopes C; Hughes CM; McLelland E; Gullick WJ; Filipe MI
    Br J Cancer; 1991 Jul; 64(1):79-83. PubMed ID: 1677259
    [No Abstract]   [Full Text] [Related]  

  • 58. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
    Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E
    Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association of elevated expression of the c-erbB-2 protein with spread of breast cancer.
    Yamada Y; Yoshimoto M; Murayama Y; Ebuchi M; Mori S; Yamamoto T; Sugano H; Toyoshima K
    Jpn J Cancer Res; 1989 Dec; 80(12):1192-8. PubMed ID: 2576425
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Simultaneous analysis of c-erbB-2 expression and DNA content in breast cancer using flow cytometry.
    Stål O; Sullivan S; Sun XF; Wingren S; Nordenskjöld B
    Cytometry; 1994 Jun; 16(2):160-8. PubMed ID: 7924685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.